SCHEMBL17814784

SCHEMBL17814784

CCC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(CCC(=O)OC)C(=O)NC(C(=O)NC(CC(=O)OC)C(=O)CF)C(C)O

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
REN P00797 2/20 0.52
CASP3 P42574 5/20 0.51
CASP1 P29466 3/20 0.51
CASP9 P55211 3/20 0.51
CASP4 P49662 2/20 0.51
CASP5 P51878 2/20 0.51
CASP6 P55212 2/20 0.51
CASP8 Q14790 2/20 0.51
CASP10 Q92851 2/20 0.51
CTSB P07858 7/20 0.49
CTSL P07711 3/20 0.49
CTSS P25774 3/20 0.49
CTSK P43235 6/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 1/20 0.47
PSMB5 P28074 1/20 0.45
CASP7 P55210 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28714127 1.00 REN (0.52) RENCASP3CASP1CASP9CASP4
SCHEMBL29449496 1.00 REN (0.52) RENCASP3CASP1CASP9CASP4
SCHEMBL20257265 0.94 CASP3 (0.57) RENCASP3CASP1CASP9CASP4
SCHEMBL21481085 0.94 CASP3 (0.57) RENCASP3CASP1CASP9CASP4
SCHEMBL29612356 0.94 CASP3 (0.57) RENCASP3CASP1CASP9CASP4
SCHEMBL23133287 0.94 CASP3 (0.57) RENCASP3CASP1CASP9CASP4
SCHEMBL23133285 0.94 CASP3 (0.57) RENCASP3CASP1CASP9CASP4
SCHEMBL23613622 0.90 CASP3 (0.56) RENCASP3CASP1CASP9CASP4
SCHEMBL23133260 0.89 REN (0.51) RENCTSBCTSLCTSSCTSK
SCHEMBL29946166 0.89 REN (0.51) RENCTSBCTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163459-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC PHARMACEUTICALS GMBH (DE) 2025-05-22 US claimed
EP-4486872-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC Pharmaceuticals GmbH (DE) 2025-01-08 EP claimed
CN-118804973-A Improved cell lines and methods for producing adeno-associated vectors 塞维克制药有限责任公司 2024-10-18 CN claimed
WO-2023166026-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC PHARMACEUTICALS GMBH (DE) 2023-09-07 WO claimed
EP-4239063-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC Pharmaceuticals GmbH (DE) 2023-09-06 EP claimed
US-20250163459-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC PHARMACEUTICALS GMBH (DE) 2025-05-22 US disclosed
EP-4486872-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC Pharmaceuticals GmbH (DE) 2025-01-08 EP disclosed
CN-118804973-A Improved cell lines and methods for producing adeno-associated vectors 塞维克制药有限责任公司 2024-10-18 CN disclosed
WO-2023166026-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC PHARMACEUTICALS GMBH (DE) 2023-09-07 WO disclosed
EP-4239063-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC Pharmaceuticals GmbH (DE) 2023-09-06 EP disclosed
CN-113521286-B Coronavirus protease inhibitors and uses thereof 中国医学科学院基础医学研究所 2023-08-18 CN disclosed
CN-113521286-A Coronavirus protease inhibitor and application thereof 中国医学科学院基础医学研究所 2021-10-22 CN disclosed
WO-2016090169-A1 INTRACELLULAR CASPASE PROBES FOR DETECTION OF APOPTOSIS AND INFLAMMATION AND KITS CONTAINING SUCH PROBES SEED RESEARCH AND DEVELOPMENT LLC (US) 2016-06-09 WO disclosed